$ECL

Ecolab 3Q 2026: Revenue $4.69B, Net income $554.4M, EPS $1.95— 10-Q Summary

Ecolab reported Q3 2026 revenue of $4.69B, up 12.7% YoY, but net income fell 6% to $554.4M and EPS declined 4.9% to $1.95. Organic sales grew 7%, driven by pricing and volume. High-Tech sales surged 63%, while other segments also saw growth. Energy surcharges helped offset costs, and management expects pricing and productivity to counter pressures.

Original reporting
Published Oct 29, 2026, 8:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 8:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ecolab 3Q 2026: Revenue $4.69B, Net income $554.4M, EPS $1.95— 10-Q Summary — source image
Decision brief

The 30-second read

$ECLBullishHigh
01

Why it matters

The mixed results suggest short‑term price pressure but highlight growth areas that could be catalysts for longer‑term investors.

02

Market read

Ecolab's earnings release is a primary corporate event with material financial data, influencing its stock and the broader industrial sector.

03

What to watch

Energy surcharge offsetting costs and integration of Ovivo Electronics may boost future margins.

Relevance 8/10Novelty 9/10Timing: after-hours release

Background

Ecolab's Q3 2026 filing provides the first public disclosure of its quarterly performance.

Company-level read

Ticker impact

$ECLBullishHigh confidence
Context

Ecolab posted Q3 2026 revenue of $4.69B (up 12.7%) but net income fell 6% to $554.4M and EPS dropped 4.9% to $1.95.

Expected impact

modest downside pressure as investors digest lower profit despite top‑line growth

Evidence & confidence

Revenue beat expectations while net income and EPS missed, indicating cost pressures that could temper price gains.

Market effects

Water and specialty chemicals sector may see scrutiny on cost management trends.

U.S. industrials could experience slight pullback pending earnings reactions.

Limited to investors tracking mid‑cap industrials and ESG‑focused portfolios.

Counterpoint

Despite profit decline, strong organic sales and pricing initiatives could support upside if cost controls improve.

Key entities

  • Ecolab Inc.

    Global provider of water, hygiene and infection prevention solutions.

Related articles

$ECLMedAI 8/10

Ecolab Inc (ECL) (Q3 2026) Earnings Call Highlights: 7% Organic Sales Growth, 63%

Ecolab Inc (ECL) reported 7% organic sales growth in Q3 2026, with High-Tech segment growing 63%. Challenges include North American restaurant traffic decline, commodity cost inflation, and a 1% growth headwind from the Middle East. CoolIT acquisition is expected to impact EPS. CEO Christophe Beck reaffirmed 2027 margin targets and growth expectations, citing strong demand in High-Tech and Life Sciences.

$ECLMed

Ecolab (ECL) Q3 2026 Earnings Call Transcript

Ecolab (ECL) reported Q3 2026 pro forma sales growth of high single digits and adjusted EPS growth of mid-teens. The company highlighted strong performance in Food & Beverage, Life Sciences, and Global High-Tech, with organic sales growth of 8%, 17%, and 63% respectively. Ecolab also emphasized its One Ecolab model, which integrates water, hygiene, and digital solutions to drive customer value and growth. The company plans to expand field sales and service offerings to accelerate growth further.

$ECLMedAI 8/10

Ecolab Q3 Earnings Call Highlights

Ecolab (ECL) reported Q3 growth in Life Sciences (17%), Ecolab Digital (34%), and Pest Elimination (8%). Global High-Tech saw 63% growth, driven by data-center cooling and water systems. Ecolab expects 2027 organic sales growth at the upper end of its 5%-7% target range and adjusted operating-income margin of 20%. The company is integrating recent acquisitions and reducing leverage.

$ECLHighAI 8/10

Ecolab Q3 2026 slides: organic growth accelerates to 7%, margins expand

Ecolab (ECL) reported Q3 2026 results with 7% organic sales growth, 13% total sales growth, and adjusted EPS of $2.18, slightly above estimates. Revenue was $4.69B, below consensus. Stock rose 1.29% premarket. High-growth segments like Global High-Tech and Life Sciences drove performance. Management expects full-year EPS of $8.10-$8.20 and 2027 margin target of 20%.

$ECLMedAI 8/10

Ecolab Q3 Earnings In-Line With Estimates, Revenues Increase Y/Y

Ecolab reported Q3 2026 adjusted earnings of $2.18 per share, up 5% Y/Y, matching estimates. Revenues rose 13% to $4.69B, beating estimates. Organic sales increased 7%, with strong demand in Global High-Tech and Life Sciences. ECL raised its 2026 adjusted earnings outlook to $8.10-$8.20 per share, citing acquisitions and pricing gains.